Abstract
Expert opinion on the use of SGLT2 inhibitors and its combination with a special focus on dapagliflozin in the management of type 2 diabetes in Indian settings
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
